Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

The findings were presented at the 17th Clinical Trials on Alzheimer's Disease (CTAD) conference. Metabolic and vascular ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...